Dr. Rick Adam Friedman, MD, PhD

Dr. Friedman practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Friedman's NPI, 1982708558, was assigned on September 12, 2006. Dr. Friedman graduated from UC San Diego School of Medicine in 1988. Dr. Friedman holds California license G67571.

Dr. Friedman's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Dr. Friedman's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Friedman is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health. Dmand AI also links Dr. Friedman to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Friedman practices. Vendor and product names are available with a free account.

Otology and neurotology is Dr. Friedman's primary specialty in the NPI Registry, under taxonomy code 207YX0901X. Dr. Friedman is board certified in neurotology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Friedman's licenses on file in 2 states: California and Ohio.

Dmand AI lists ear eustachian tube disorders, ear infection, hearing loss and impairment, swimmer's ear, tinnitus and vertigo among the conditions Dr. Friedman treats.

CMS data shows 101 Medicare services from Dr. Friedman across 3 procedure codes in 2024, all of them office visits, for 88 Medicare patients. Medicare paid $10,602 for them. Every service was in an office.

CMS counts 88 Medicare patients who saw Dr. Friedman in 2024. The largest group is 65 to 74, with 48 patients. 73% of them have high cholesterol, and 58% have high blood pressure. 13% are also on Medicaid. Their average risk score is 1.00, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Friedman's median patient age at 54, with 52% women.

In 2024, Dr. Friedman wrote 15 Medicare Part D claims. 93% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Friedman for performance year 2024, reported as part of a group. Dr. Friedman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 146 papers to Dr. Friedman, published from 2002 to 2025. 2021 was the busiest year, with 10. The most frequent topics are Neuroma, Acoustic, Cochlea and Genome-Wide Association Study. Dr. Friedman has published most often in Otol Neurotol. Dr. Friedman's most frequent co-authors are Marc Schwartz, MD, Marc Stuart Schwartz, MD and Omid Moshtaghi, MD.

CMS Open Payments shows 13 general payments to Dr. Friedman from 5 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Cochlear Ltd paid the most, $499.

Dmand AI lists 8 awards for Dr. Friedman, most recently Regional Top Doctor in 2014. Dr. Friedman serves on Acoustic Neuroma Association.

Dr. Friedman graduated from UC San Diego School of Medicine in 1988. Dr. Friedman is a member of NHS.

Dr. Friedman is in network with 15 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.